Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   CEPS(Rs) 40.9738.6634.8529.4027.71

What is the latest Cash Earnings per Share (CEPS) ratio of LINCOLN PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of LINCOLN PHARMACEUTICALS is 40.97 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202340.97
Mar202238.66
Mar202134.85
Mar202029.40
Mar201927.71

How is Cash Earnings per Share (CEPS) of LINCOLN PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 40.97
5.98
Mar2022 38.66
10.93
Mar2021 34.85
18.54
Mar2020 29.4
6.10
Mar2019 27.71 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,176.8 Cr -1.1% -3.6% 52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.1%

-3.6%

52.7%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses